Clinic
Allstar Pediatrics
Allstar Pediatrics was paid $8.72M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.
33Billing provider infoALLSTAR PEDIATRICS
LEESVILLE, LA 71446
LEESVILLE, LA 71446
33aNPI1215174958assigned 01/16/2009
33bProvider typePrimary Care Clinic/Center
28Total paid$8.72M
24GClaims274,361
24DCodes billed75
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Louisiana
Rank by total paid#2 of 92
Median peer was paid$157K
This provider vs. median55×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,598 | $850K | |
| 2019 | 40,287 | $1.02M | |
| 2020 | 38,547 | $1.04M | |
| 2021 | 40,155 | $1.53M | |
| 2022 | 42,777 | $1.66M | |
| 2023 | 46,916 | $1.58M | |
| 2024incomplete | 35,081 | $1.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 25,272 | 18,572 | $1.60M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 28,810 | 18,233 | $1.29M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 12% | 3,216 | 2,493 | $1.01M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.6% | 6,750 | 5,610 | $490K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.0% | 16,308 | 14,153 | $437K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.4% | 18,906 | 13,480 | $387K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.1% | 5,736 | 5,133 | $359K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.0% | 5,551 | 5,198 | $345K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.4% | 8,678 | 6,185 | $293K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 4,879 | 3,314 | $292K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.0% | 3,930 | 3,634 | $264K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.8% | 23,126 | 16,610 | $244K |
63 more codes
| 94667 | 2.6% | 17,256 | $230K | |
| 94010 | 2.1% | 8,827 | $186K | |
| 17110 | 2.1% | 2,721 | $182K | |
| 87634 | 1.8% | 2,856 | $153K | |
| 94664 | 1.4% | 13,707 | $126K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.0% | 6,951 | $91K |
| 94016 | <1% | 5,120 | $85K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 4,766 | $83K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 3,015 | $80K |
| 92551 | <1% | 10,192 | $75K | |
| 87807 | <1% | 5,719 | $62K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,520 | $60K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 608 | $47K |
| 80305 | <1% | 5,031 | $43K | |
| 99188 | <1% | 1,576 | $31K | |
| 99223 | Prolong inpt eval add15 m | <1% | 196 | $28K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,494 | $21K |
| 92567 | <1% | 1,742 | $20K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 259 | $19K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 325 | $18K |
| 99173 | <1% | 8,375 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 354 | $10K |
| 69210 | <1% | 370 | $9K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 128 | $8K |
| 81025 | <1% | 884 | $5K | |
| 90473 | <1% | 420 | $4K | |
| 81002 | <1% | 2,370 | $4K | |
| 83655 | <1% | 235 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 331 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 133 | $2K |
| 0001A | <1% | 53 | $2K | |
| 86328 | <1% | 43 | $2K | |
| 0002A | <1% | 41 | $2K | |
| 86318 | <1% | 136 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $1K |
| 0071A | <1% | 34 | $1K | |
| 99382 | <1% | 13 | $1K | |
| 0072A | <1% | 16 | $663.48 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 325 | $650.20 |
| 86308 | <1% | 139 | $621.89 | |
| 85014 | <1% | 255 | $538.11 | |
| 99464 | <1% | 16 | $532.17 | |
| 90734 | <1% | 560 | $139.26 | |
| 90656 | <1% | 101 | $133.52 | |
| 82570 | <1% | 31 | $103.00 | |
| 90620 | <1% | 12 | $75.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 18 | $73.79 |
| 90671 | <1% | 157 | $71.34 | |
| 82044 | <1% | 32 | $66.66 | |
| 90686 | <1% | 1,210 | $19.58 | |
| 90681 | <1% | 348 | $2.77 | |
| 90633 | <1% | 886 | $0.20 | |
| 90651 | <1% | 300 | $0.03 | |
| 90744 | 0% | 654 | $0.00 | |
| 90716 | 0% | 634 | $0.00 | |
| 91307 | 0% | 83 | $0.00 | |
| 90648 | 0% | 1,762 | $0.00 | |
| 90700 | 0% | 2,458 | $0.00 | |
| 90670 | 0% | 1,460 | $0.00 | |
| 90713 | 0% | 2,017 | $0.00 | |
| 90715 | 0% | 146 | $0.00 | |
| 90707 | 0% | 661 | $0.00 | |
| 91300 | 0% | 105 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBEG, MIRZA (CEO)